Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials-Reference-Cited by-同舟云学术

Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials

Published:2008-09-16 Issue:5 Volume:10 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Loibl Sibylle,von Minckwitz Gunter,Harbeck Nadia,Janni Wolfgang,Elling Dirk,Kaufmann Manfred,Eggemann Holm,Nekljudova Valentina,Sommer Harald,Kiechle Marion,Kümmel Sherko

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr2144.pdf

Reference30 articles.

1. Roche H, Fumoleau P, Spielmann M, Canon JL, Delozier T, Serin D, Symann M, Kerbrat P, Soulie P, Eichler F, Viens P, Monnier A, Vindevoghel A, Campone M, Goudier MJ, Bonneterre J, Ferrero JM, Martin AL, Geneve J, Asselain B: Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 trial. J Clin Oncol. 2006, 24: 5664-5671. 10.1200/JCO.2006.07.3916.

2. Crivellari D, Aapro M, Leonard R, von Minckwitz G, Brain E, Goldhirsch A, Veronesi A, Muss H: Breast cancer in the elderly. J Clin Oncol. 2007, 25: 1882-1890. 10.1200/JCO.2006.10.2079.

3. Rack B, Janni W, Harbeck N, Heinrigs M, Augustin D: Phase III study evaluating the role of docetaxel in the adjuvant therapy of breast cancer patients with extensive lymph node involvement (= 4 LK+) – ADEBAR study [abstract]. Breast. 2003, 12: 78-10.1016/S0960-9776(03)80117-0.

4. von Minckwitz G, Raab G, Caputo A, Schutte M, Hilfrich J, Blohmer JU, Gerber B, Costa SD, Merkle E, Eidtmann H, Lampe D, Jackisch C, du Bois A, Kaufmann M: Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group. J Clin Oncol. 2005, 23: 2676-2685. 10.1200/JCO.2005.05.078.

5. von Minckwitz G, Kummel S, Vogel P, Hanusch C, Eidtmann H, Hilfrich J, Gerber B, Huober J, Costa SD, Jackisch C, Loibl S, Mehta K, Kaufmann M: Neoadjuvant vinorelbine–capecitabine versus docetaxel–doxorubicin–cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial. J Natl Cancer Inst. 2008, 100: 542-551. 10.1093/jnci/djn085.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tolerance and Outcomes of Neoadjuvant Chemotherapy in Geriatric Breast Cancer Patients;Journal of Surgical Research;2023-03

2. Systemic therapy for older patients with early breast cancer;Cancer Treatment Reviews;2021-11

3. Mucinous carcinoma in an octogenarian: Treatment and management of breast cancer in the elderly;Radiology Case Reports;2021-11

4. Efficacy and safety of cyclophosphamide in anthracycline- and taxane-based neoadjuvant chemotherapy in breast cancer: a meta-analysis;Gland Surgery;2021-01

5. Continuation of Annual Screening Mammography and Breast Cancer Mortality in Women Older Than 70 Years;Annals of Internal Medicine;2020-02-25